CompanyScope

Boston Scientific Corporation income statement & cash flow

Ticker BSX · SEC CIK 885725 · Latest fiscal year ended Dec 31, 2025

In the fiscal year ended Dec 31, 2025, Boston Scientific Corporation reported net income of $2.89B on revenue of $20.07B. Operating cash flow was $4.53B and capital expenditures were $876.00M, leaving $3.66B of free cash flow (operating cash flow minus capital expenditures).

−$2B$0$2B$4B$6BDec 2016: $347.00MDec 2017: $104.00MDec 2018: $1.67BDec 2019: $4.70BDec 2020: −$82.00MDec 2021: $1.04BDec 2022: $698.00MDec 2023: $1.59BDec 2024: $1.85BDec 2025: $2.89BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Boston Scientific Corporation net income by fiscal year, USD. Hover a bar for the exact figure.

Income statement and cash flow summary

Fiscal year endedDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue (USD)$9.08B$9.05B$9.82B$10.73B$9.91B$11.89B$12.68B$14.24B$16.75B$20.07B
Gross profit (USD)$5.96B$6.46B$7.01B$7.62B$6.45B$8.18B$8.73B$9.90B$11.49B$13.85B
Operating income (USD)$447.00M$1.28B$1.51B$1.52B−$80.00M$1.20B$1.65B$2.34B$2.60B$3.61B
Net income (USD)$347.00M$104.00M$1.67B$4.70B−$82.00M$1.04B$698.00M$1.59B$1.85B$2.89B
Diluted EPS (USD per share)$0.25$0.08$1.19$3.33−$0.08$0.69$0.45$1.07$1.25$1.94
Operating cash flow (USD)$1.18B$1.43B$310.00M$1.84B$1.51B$1.87B$1.53B$2.50B$3.44B$4.53B
Capital expenditures (USD)$376.00M$319.00M$316.00M$461.00M$376.00M$554.00M$588.00M$711.00M$790.00M$876.00M
Reported in10-K 201910-K 202010-K 202110-K 202210-K 202310-K 202410-K 202510-K 202610-K 202610-K 2026

Columns are fiscal years, labeled by the month the year ended; scroll sideways on small screens. — means the company did not report the figure under the XBRL concepts we track.

Margins

Each figure divided by revenue for the same fiscal year.

Fiscal year endedGross marginOperating marginNet margin
Dec 202569.0%18.0%14.4%
Dec 202468.6%15.5%11.0%
Dec 202369.5%16.5%11.2%
Dec 202268.8%13.0%5.5%
Dec 202168.8%10.1%8.8%
$0$2B$4B$6BDec 2016: $1.18BDec 2017: $1.43BDec 2018: $310.00MDec 2019: $1.84BDec 2020: $1.51BDec 2021: $1.87BDec 2022: $1.53BDec 2023: $2.50BDec 2024: $3.44BDec 2025: $4.53BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Boston Scientific Corporation operating cash flow by fiscal year, USD. Hover a bar for the exact figure.

Source: SEC EDGAR XBRL company facts for CIK 885725 (raw data). Most recent filing in this dataset: 10-Q filed Nov 2, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.